AAPL vs MLAB
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
Apple exhibits a stable financial foundation with a Piotroski F-Score of 6/9, though it currently trades at a significant premium to its intrinsic value of $233.05 and Graham Number of $32.65. While the company demonstrates elite profitability with an ROE of 152.02% and a consistent track record of earnings beats over 25 quarters, valuation metrics are stretched with a PEG ratio of 2.27. The outlook is tempered by bearish insider activity from the CEO and CFO, alongside a technical trend score of 0/100, suggesting a period of consolidation or correction despite strong fundamental growth.
MLAB exhibits a stable financial health profile with a Piotroski F-Score of 6/9, but it is fundamentally disconnected from its valuation. The stock trades at a massive premium to its Graham Number ($22.23) and Intrinsic Value ($4.55), with a trailing P/E of 150.54. While the forward P/E of 18.15 suggests an expected earnings recovery, the current dividend payout ratio of 98.46% is unsustainable. Long-term price performance is severely negative, indicating a persistent lack of value creation over a 5-year horizon.
Compare Another Pair
Related Comparisons
AAPL vs MLAB: Head-to-Head Comparison
This page compares Apple Inc. (AAPL) and Mesa Laboratories, Inc. (MLAB) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.